Lergotrile mesylate

TargetMol
Product Code: TAR-T25671L
Supplier: TargetMol
CodeSizePrice
TAR-T25671L-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25671L-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25671L-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Lergotrile mesylate, an ergoline derivative, suppresses prolactin in vivo and in vitro.
CAS:
51473-23-5
Formula:
C18H22ClN3O3S
Molecular Weight:
395.9
Purity:
0.98
SMILES:
CS(O)(=O)=O.[H][C@@]12Cc3c(Cl)[nH]c4cccc(c34)[C@@]1([H])C[C@@H](CC#N)CN2C

References

1. Sherman BM, Swanson JA, Chapler FK. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate. Fertil Steril. 1978 Mar;29(3):291-5. PubMed PMID: 565303. 2. Clemens JA, Smalstig EB, Shaar CJ. Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action. Acta Endocrinol (Copenh). 1975 Jun;79(2):230-7. PubMed PMID: 166535. 3. Schmidt MJ. Dopamine agonist-induced hyperglycemia in rats: effects of lergotrile mesylate. Eur J Pharmacol. 1979 Oct 26;59(1-2):95-101. PubMed PMID: 41730. 4. Lieberman A, Estey E, Kupersmith M, Gopinathan G, Goldstein M. Treatment of Parkinson's disease with lergotrile mesylate. JAMA. 1977 Nov 28;238(22):2380-2. PubMed PMID: 335094.